Stan Bukofzer, SVP, Chf Scitfc & Technology Officer at Assertio Therapeutics, Inc (ASRT), bought 4,000 shares at $1.56 ($6K) on 2019-08-13, disclosed to the SEC on 2019-08-14.
Open-market purchase of $6k ASRT by SVP, Chf Scitfc & Technology Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |